West Pharmaceutical Services (WST) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $383.02, +2.23% vs the prior close of $374.65.
- Volume 390.40K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
WST rises 2.2% to $383.02, a 52-week high, 5 up days in a row. Closed at $383.02, +2.23% vs the prior close of $374.65. Day range $376.10–$384.40, opened at $377.00.
WST daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — WST rises 2.2% to $383.02, a 52-week high, 5 up days in a row
- Closed at $383.02, +2.23% vs the prior close of $374.65. Day range $376.10–$384.40, opened at $377.00.
- Volume was 390.40K shares, 0.7x its 50-day average of 531.53K.
- Price is +7.2% vs its 50-day average ($357.43) and +24.9% vs its 200-day average ($306.75).
- 52-week range $223.83–$386.00; today's close sits at 98% of that range, 0.8% below the 52-week high.
- That makes 5 straight gains.
Oct 14, 2026 — WST rises 0.8% to $374.65, 4 up days in a row
- Closed at $374.65, +0.76% vs the prior close of $371.82. Day range $372.21–$379.21, opened at $372.21.
- Volume was 444.60K shares, 0.8x its 50-day average of 532.28K.
- Price is +5.0% vs its 50-day average ($356.79) and +22.3% vs its 200-day average ($306.22).
- 52-week range $223.83–$386.00; today's close sits at 93% of that range, 2.9% below the 52-week high.
- That makes 4 straight gains.
Oct 13, 2026 — WST rises 1.1% to $371.82, 3 up days in a row
- Closed at $371.82, +1.15% vs the prior close of $367.60. Day range $367.50–$378.84, opened at $369.54.
- Volume was 507.60K shares, 0.9x its 50-day average of 534.99K.
- Price is +4.4% vs its 50-day average ($356.27) and +21.6% vs its 200-day average ($305.71).
- 52-week range $223.83–$386.00; today's close sits at 91% of that range, 3.7% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — WST rises 0.4% to $367.60
- Closed at $367.60, +0.44% vs the prior close of $366.00. Day range $363.10–$371.76, opened at $366.72.
- Volume was 357.30K shares, 0.7x its 50-day average of 548.79K.
- Price is +3.3% vs its 50-day average ($355.80) and +20.4% vs its 200-day average ($305.24).
- 52-week range $223.83–$386.00; today's close sits at 89% of that range, 4.8% below the 52-week high.
Oct 9, 2026 — WST rises 0.8% to $366.00
- Closed at $366.00, +0.75% vs the prior close of $363.27. Day range $362.18–$370.20, opened at $363.31.
- Volume was 480.20K shares, 0.9x its 50-day average of 550.47K.
- Price is +3.0% vs its 50-day average ($355.26) and +20.1% vs its 200-day average ($304.79).
- 52-week range $223.83–$386.00; today's close sits at 88% of that range, 5.2% below the 52-week high.
Oct 8, 2026 — WST dips 0.9% to $363.27, 3 down days in a row
- Closed at $363.27, -0.88% vs the prior close of $366.48. Day range $359.49–$367.25, opened at $365.65.
- Volume was 461.70K shares, 0.8x its 50-day average of 559.68K.
- Price is +2.4% vs its 50-day average ($354.74) and +19.4% vs its 200-day average ($304.33).
- 52-week range $223.83–$386.00; today's close sits at 86% of that range, 5.9% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — WST dips 1.7% to $366.48
- Closed at $366.48, -1.65% vs the prior close of $372.64. Day range $365.35–$374.79, opened at $371.66.
- Volume was 438.00K shares, 0.8x its 50-day average of 568.45K.
- Price is +3.5% vs its 50-day average ($354.22) and +20.6% vs its 200-day average ($303.88).
- 52-week range $223.83–$386.00; today's close sits at 88% of that range, 5.1% below the 52-week high.
Oct 6, 2026 — WST dips 1.1% to $372.64
- Closed at $372.64, -1.09% vs the prior close of $376.76. Day range $367.64–$381.16, opened at $379.02.
- Volume was 401.40K shares, 0.7x its 50-day average of 592.53K.
- Price is +5.4% vs its 50-day average ($353.63) and +22.8% vs its 200-day average ($303.39).
- 52-week range $223.83–$386.00; today's close sits at 92% of that range, 3.5% below the 52-week high.
Oct 5, 2026 — WST jumps 3.2% to $376.76, a 52-week high
- Closed at $376.76, +3.23% vs the prior close of $364.98. Day range $363.16–$377.06, opened at $364.69.
- Volume was 682.70K shares, 1.1x its 50-day average of 609.05K.
- Price is +6.8% vs its 50-day average ($352.80) and +24.4% vs its 200-day average ($302.87).
- 52-week range $223.83–$386.00; today's close sits at 94% of that range, 2.4% below the 52-week high.
Oct 2, 2026 — WST ends flat (-0.0%) to $364.98, 3 down days in a row
- Closed at $364.98, -0.01% vs the prior close of $365.01. Day range $363.26–$368.85, opened at $364.74.
- Volume was 473.00K shares, 0.7x its 50-day average of 635.55K.
- Price is +3.7% vs its 50-day average ($351.83) and +20.7% vs its 200-day average ($302.32).
- 52-week range $223.83–$386.00; today's close sits at 87% of that range, 5.4% below the 52-week high.
- That makes 3 straight losses.
WST latest news & SEC filings
Every SEC filing by or about WST in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 15, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Favorite Annette F sold 2,524 shares at $365.00 (≈$921.26K) on Sep 15, 2026
- Favorite Annette F sold 2,500 shares at $355.00 (≈$887.50K) on Sep 14, 2026
- Favorite Annette F sold 2,500 shares at $345.00 (≈$862.50K) on Sep 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Favorite Annette F sold 2,818 shares at $340.81 (≈$960.40K) on Sep 8, 2026
- Favorite Annette F sold 2,500 shares at $340.81 (≈$852.02K) on Sep 8, 2026
- Favorite Annette F sold 2,817 shares at $340.81 (≈$960.06K) on Sep 8, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 10, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 12, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 6, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 23, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $872.30M (prior year $766.50M) (+13.8% vs Jun 30, 2025)
- Net income: $154.00M (prior year $131.80M) (+16.8% vs Jun 30, 2025)
- Diluted EPS: $2.15 (prior year $1.82) (+18.1% vs Jun 30, 2025)
Jul 23, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 14, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Things to know before you trade WST
- Last results release: Jul 23, 2026 (8-K Item 2.02). Previous ones: Apr 23, 2026, Feb 12, 2026, Oct 23, 2025. Based on that rhythm, the next report is likely around Oct 22, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.18% (largest 3.2%).
- Liquidity: about 581.34K shares (≈$222.66M) trade per day on average.
- 52-week position: $383.02 vs a range of $223.83–$386.00 (98% of the range).
- Dividends: last ex-dividend date Jul 29, 2026 ($0.22/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 8 sales; latest: Annette F Favorite sold 2,524 shares on Sep 15, 2026.
- Latest filings: 10-Q Jul 23, 2026; 8-K Jul 23, 2026; 8-K Jul 14, 2026.
- Share count: 70.38M shares outstanding (Jul 20, 2026), -2.1% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Surgical & Medical Instruments & Apparatus.
WST market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 377.00 | 384.40 | 376.10 | 383.02 | 390.40K |
| Oct 14, 2026 | 372.21 | 379.21 | 372.21 | 374.65 | 444.60K |
| Oct 13, 2026 | 369.54 | 378.84 | 367.50 | 371.82 | 507.60K |
| Oct 12, 2026 | 366.72 | 371.76 | 363.10 | 367.60 | 357.30K |
| Oct 9, 2026 | 363.31 | 370.20 | 362.18 | 366.00 | 480.20K |
| Oct 8, 2026 | 365.65 | 367.25 | 359.49 | 363.27 | 461.70K |
| Oct 7, 2026 | 371.66 | 374.79 | 365.35 | 366.48 | 438.00K |
| Oct 6, 2026 | 379.02 | 381.16 | 367.64 | 372.64 | 401.40K |
| Oct 5, 2026 | 364.69 | 377.06 | 363.16 | 376.76 | 682.70K |
| Oct 2, 2026 | 364.74 | 368.85 | 363.26 | 364.98 | 473.00K |
| Oct 1, 2026 | 367.52 | 370.25 | 363.12 | 365.01 | 670.90K |
| Sep 30, 2026 | 375.35 | 376.19 | 370.13 | 370.76 | 471.20K |
| Sep 29, 2026 | 375.51 | 377.78 | 370.80 | 376.63 | 560.10K |
| Sep 28, 2026 | 366.55 | 378.47 | 366.55 | 375.65 | 562.30K |
| Sep 25, 2026 | 372.01 | 372.14 | 368.45 | 370.44 | 434.00K |
| Sep 24, 2026 | 378.67 | 382.71 | 370.71 | 373.60 | 715.90K |
| Sep 23, 2026 | 370.93 | 376.06 | 368.20 | 375.87 | 876.90K |
| Sep 22, 2026 | 367.42 | 375.40 | 365.26 | 371.09 | 734.70K |
| Sep 21, 2026 | 363.78 | 366.12 | 361.05 | 361.78 | 506.80K |
| Sep 18, 2026 | 366.59 | 366.86 | 359.52 | 362.31 | 1.46M |
About West Pharmaceutical Services
West Pharmaceutical Services (WST) is listed on the NYSE and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in EXTON, PA. State of incorporation: PA. Fiscal year ends December 31. SEC CIK 105770.
WST board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Mark A Buthman | Director | May 6, 2026 |
| Robert F Friel | Director | May 6, 2026 |
| William F Feehery | Director | May 6, 2026 |
| Eric Mark Green | President, CEO and Board Chair | Mar 3, 2026 |
| Janet Brutschea Haugen | Director | Jul 1, 2026 |
| Molly Joseph | Director | May 6, 2026 |
| Deborah L Keller | Director | May 6, 2026 |
| Goldman Myla Lai | Director | May 6, 2026 |
| Michel Lagarde | President and CEO | Sep 10, 2026 |
| Stephen H Lockhart | Director | May 6, 2026 |
| Douglas A Michels | Director | May 6, 2026 |
| Paolo Pucci | Director | May 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Shane Alden Campbell | SVP, Proprietary Segment | May 14, 2026 |
| Annette F Favorite | Sr. VP & Chief HR Officer | Sep 15, 2026 |
| Norman D. Jr. Finch | SVP, GC & Corporate Secretary | Mar 3, 2026 |
| Eric Mark Green | President, CEO and Board Chair | Mar 3, 2026 |
| Michel Lagarde | President and CEO | Sep 10, 2026 |
| Robert W. Mcmahon | SVP & Chief Financial Officer | Aug 12, 2026 |
| Rodolphe Jean Poussot | SVP, Strategy & Corporate Dev | Mar 3, 2026 |
| Chad Winters | VP, Chief Accounting Officer | Apr 29, 2026 |
| Charles Witherspoon | VP & Treasurer | Feb 23, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 15, 2026 | Annette F Favorite | Sale | 2,524 | $365.00 |
| Sep 14, 2026 | Annette F Favorite | Sale | 2,500 | $355.00 |
| Sep 11, 2026 | Annette F Favorite | Sale | 2,500 | $345.00 |
| Sep 8, 2026 | Annette F Favorite | Sale | 2,818 | $340.81 |
| Sep 8, 2026 | Annette F Favorite | Sale | 2,500 | $340.81 |
| Sep 8, 2026 | Annette F Favorite | Sale | 2,817 | $340.81 |
| Apr 27, 2026 | Chad Winters | Sale | 896 | $300.67 |
| Apr 27, 2026 | Annette F Favorite | Sale | 2,817 | $305.20 |
WST financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $3.07B | $493.70M | 6.79 | $754.80M |
| Dec 31, 2024 | $2.89B | $492.70M | 6.69 | $653.40M |
| Dec 31, 2023 | $2.95B | $593.40M | 7.88 | $776.50M |
| Dec 31, 2022 | $2.89B | $585.90M | 7.73 | $724.00M |
| Dec 31, 2021 | $2.83B | $661.80M | 8.67 | $584.00M |
Latest balance sheet: total assets $4.08B, total liabilities $1.09B, cash $435.80M (as of Jun 30, 2026).
WST earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 23, 2026 | 8-K Item 2.02 (results) | $355.48 |
| Apr 23, 2026 | 8-K Item 2.02 (results) | $309.70 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $243.61 |
| Oct 23, 2025 | 8-K Item 2.02 (results) | $307.25 |
| Jul 24, 2025 | 8-K Item 2.02 (results) | $279.10 |
| Apr 24, 2025 | 8-K Item 2.02 (results) | $210.59 |
| Feb 13, 2025 | 8-K Item 2.02 (results) | $199.11 |
| Oct 24, 2024 | 8-K Item 2.02 (results) | $330.65 |
| Jul 25, 2024 | 8-K Item 2.02 (results) | — |
| Apr 25, 2024 | 8-K Item 2.02 (results) | — |
| Feb 15, 2024 | 8-K Item 2.02 (results) | — |
| Oct 26, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)Globus Medical (GMED)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on WST
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.